Ensign Peak Advisors, Inc Passage Bio, Inc. Transaction History

Ensign Peak Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.63 - $3.46 $21,630 - $45,914	-13,270 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.24 - $10.2 $82,804 - $135,354	13,270 New	13,270 $84,000
Q3 2021 Nov 12, 2021	SELL	$9.73 - $15.52 $249,574 - $398,088	-25,650 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$16.24 - $29.83 $416,555 - $765,139	25,650 New	25,650 $448,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.